Home/QuantX Biosciences/Yax Sun, Ph.D.
YS

Yax Sun, Ph.D.

Co-founder, Chief Technology Officer

QuantX Biosciences

Therapeutic Areas

QuantX Biosciences Pipeline

DrugIndicationPhase
STAT6 inhibitorImmunology/Inflammatory diseasesPreclinical
IL-17 inhibitorImmunology/Inflammatory diseasesPreclinical